The revenue stands at ₹4,979.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.18 per cent from ₹4,921.00 crore. This corresponds to a year-on-year *(YoY) growth of 50.79 per cent.
Operating Profit stands at ₹1,656.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.79 per cent from ₹1,643.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.77 per cent.
PBDT stands at ₹1,346.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.51 per cent from ₹1,326.00 crore. This corresponds to a year-on-year *(YoY) growth of 35.28 per cent.
Profit Before Tax stands at ₹737.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.55 per cent from ₹733.00 crore. This corresponds to a year-on-year *(YoY) decline of 6.83 per cent.
Net Profit stands at ₹534.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.65 per cent from ₹566.00 crore. This represents a 9.64 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 1.56% | 1.43% | -2.66% | -7.65% | 9.01% | 27.76% |
| Sun Pharma.Inds. | 0.87% | 2.02% | -1.75% | -8.81% | -2.51% | 4.16% |
| Divi's Lab. | 0.62% | 7.11% | 4.53% | 16.73% | 46.79% | 42.75% |
| Laurus Labs | 6.55% | 16.12% | 20.26% | 32.08% | 105.06% | 145.30% |
| Zydus Lifesci. | 4.89% | 7.42% | 8.62% | 11.44% | 37.97% | 26.84% |
| Dr Reddy's Labs | 0.87% | 3.62% | 12.51% | 15.41% | 4.83% | 12.85% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta